MADELYN PELLICER: Open Payments
NPI 1114642865 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 82 payments from 20 companies in 2025. Trend: 2023 $946 · 2024 $559 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 13 | $299 |
| United Therapeutics Corporation | 8 | $210 |
| Novartis Pharmaceuticals Corporation | 9 | $165 |
| Amgen Inc. | 12 | $158 |
| Actelion Pharmaceuticals US, Inc. | 6 | $140 |
| PFIZER INC. | 5 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $95 |
| SCPHARMACEUTICALS INC. | 4 | $87 |
| Alnylam Pharmaceuticals Inc. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
Products named: Tyvaso, LEQVIO, WINREVAIR, Repatha, VERQUVO, VYNDAQEL, JARDIANCE, FUROSCIX.
Industry payments across FL — which companies pay providers there.
